A groundbreaking sensory t-shirt developed by researchers in Italy may revolutionize post-operative care for cancer patients, offering a safer and more comfortable recovery at home. Designed to monitor vital signs remotely after urological surgeries, the wearable device has shown promising results in a recent pilot study involving 70 participants. The innovative garment was created by a team from Sapienza University in Rome, in collaboration with LET Webearable Solutions, a company that specializes in remote health monitoring technologies.
The t-shirt, which is worn discreetly under clothing for three separate three-hour periods each day, contains embedded sensors that track a wide range of health metrics, including electrocardiogram (ECG) activity, heart rate, body temperature, blood pressure, blood glucose, and blood oxygen saturation. The data collected is transmitted in real-time to a dedicated smartphone app and web-based software, allowing healthcare providers to continuously monitor the patient’s condition from afar.
Professor Antonio Pastore, who led the study, explained that the objective was to determine whether the use of wearable technology could safely enable earlier hospital discharge for patients recovering from urological cancer surgery, such as bladder or prostate procedures. “The t-shirt we gave to patients differs from smartwatches and other wearables,” said Prof. Pastore. “It can reveal more data, including electrolytes, which we need to continue to monitor after bladder surgery as they can reveal mineral imbalances that lead to serious complications.”
Participants in the wearable group were thoroughly briefed on how to use the device and were discharged 24 to 36 hours earlier than those in the control group. While patients in the control group stayed in the hospital for the usual three to five days post-surgery, those equipped with the wearable device were able to return home as soon as two to four days after their operations. The results suggest that the t-shirt not only helps reduce hospital stays but also enhances patient confidence and comfort during recovery.
The impact on patient outcomes was also significant. In the control group, eight individuals (26%) required unscheduled readmission to the hospital before their follow-up appointments. In contrast, only two patients (6%) in the wearable group experienced complications serious enough to warrant an early return. Additionally, the wearable successfully detected early signs of cardiological issues in five patients, enabling prompt diagnosis and intervention—something that might not have occurred without continuous monitoring.
The average monitoring period for the wearable group was nearly 14 days, and the feedback from patients was overwhelmingly positive. “Our patients found the t-shirt easy to use and over 90% reported it allowed them to feel safe and cared for while recuperating at home,” said Prof. Pastore. “Being able to allow patients home sooner improves their quality of life as they feel more comfortable in their own environment, and it means we can free up hospital beds too.”
The findings will be presented at the upcoming European Association of Urology (EAU) Congress in Madrid, Spain. Professor Maarten Albersen, Scientific Chair of the EAU and a practicing urologist at UZ Leuven Hospital in Belgium, expressed optimism about the study’s implications. “The trial is early stage, but the insights are very interesting,” he noted. “Particularly since patients strongly accepted the wearable and it was able to detect complications in real-time and reduce unnecessary re-hospitalizations.”
Researchers are now conducting a follow-up study to assess the cost-effectiveness of the technology, which could further support its adoption in healthcare systems. If the results continue to be positive, this innovation may soon become a standard part of post-operative care, improving outcomes while simultaneously reducing healthcare burdens.
Recommended For You
